As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

As of January 17, 2023, 96.3 percent of adults in Ireland had been fully vaccinated against COVID-19. According to the manufacturers of the majority of COVID-19 vaccines currently in use in Europe, being fully vaccinated is when a person receives two doses of the vaccine. In Portugal, 94.2 percent of adults had received a full course of the COVID-19 vaccination, as well as 93.9 percent of those in Malta had been fully vaccinated. On the other hand, only 35.8 percent of adults in Bulgaria had been fully vaccinated.

Furthermore, the seven-day rate of cases across Europe shows which countries are currently worst affected by the situation. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

The number of COVID-19 vaccination doses administered per 100 people in Ireland rose to 221 as of Oct 27 2023. This dataset includes a chart with historical data for Ireland Coronavirus Vaccination Rate.

In 2022, the immunisation of measles in Ireland remained nearly unchanged at around ** percent of children aged less than one year. But still, the immunisation reached its lowest value of the observation period in 2022. Find more key insights for the immunisation in countries like Denmark, Norway, and Sweden.

View daily updates and historical trends for Ireland Coronavirus Full Vaccination Rate. Source: Our World in Data. Track economic data with YCharts analyt…

Please see FAQ for latest information on COVID-19 Data Hub Data Flows. https://covid-19.geohive.ie/pages/helpfaqs Category Field label Field Name Explanation

ExtractDate Extract Date Date the data is Extracted

Latitude Latitude

Longitude Longitude

VaccinationDate Vaccination Date Date the Vaccination occurred

Week Week Details of epidemiological weeks available here https://www.hpsc.ie/notifiablediseases/resources/epidemiologicalweeks/

TotalDailyVaccines Total Daily Vaccines

Gender Male

Female

NA

Dose Number Dose1 Dose 1

Dose2 Dose 2

SingleDose Single Dose

Vaccine Brand Moderna

Pfizer

Janssen

AstraZeneca

Age Group Partial_Age0to9 At Least One Dose Age 0 to 11 Dose 1 of Astrazenenca, MRNA or Single Dose Vaccine

Partial_Age10to19 At Least One Dose Age 12 to 19

Partial_Age20to29 At Least One Dose Age 20 to 29

Partial_Age30to39 At Least One Dose Age 30 to 39

Partial_Age40to49 At Least One Dose Age 40 to 49

Partial_Age50to59 At Least One Dose Age 50 to 59

Partial_Age60to69 At Least One Dose Age 60 to 69

Partial_Age70to79 At Least One Dose Age 70 to 79

Partial_Age80+ At Least One Dose Age80+

Partial_NA At Least One Dose Not Assigned

Age Group Cumulative ParCum_Age0to9 Cumulative Age 0 to 11 Cumulative At least One Dose Age 0 to 11

ParCum_Age10to19 Cumulative Age 12 to 19 Cumulative At least One Dose Age 12 to 19

ParCum_Age20to29 Cumulative Age 20 to 29 Cumulative At least One Dose Age 20 to 29

ParCum_Age30to39 Cumulative Age 30 to 39 Cumulative At least One Dose Age 30 to 39

ParCum_Age40to49 Cumulative Age 40 to 49 Cumulative At least One Dose Age 40 to 49

ParCum_Age50to59 Cumulative Age50 to 59 Cumulative At least One Dose Age 50 to 59

ParCum_Age60to69 Cumulative Age 60 to 69 Cumulative At least One Dose Age 60 to 69

ParCum_Age70to79 Cumulative Age 70 to 79 Cumulative At least One Dose Age 70 to 79

ParCum_80+ Cumulative Age 80+ Cumulative At least One Dose Age 80+

Age Group Cumulative Percent ParCum_NA Cumulative Age Not Assigned Cumulative At least One Dose Age Not Assigned

ParPer_Age0to9 At Least One Dose Percent Age 0 to 11 Cumulative At least One Dose Age cohort/ Age cohort population

ParPer_Age10to19 At Least One Dose Percent Age 12 to 19

ParPer_Age20to29 At Least One Dose Percent Age 20 to 29

ParPer_Age30to39 At Least One Dose Percent Age 30 to 39

ParPer_Age40to49 At Least One Dose Percent Age 40 to 49

ParPer_Age50to59 At Least One Dose Percent Age 50 to 59

ParPer_Age60to69 At Least One Dose Percent Age 60 to 69

ParPer_Age70to79 At Least One Dose Percent Age 70 to 79

ParPer_80+ At Least One Dose Percent 80+

ParPer_NA At Least One Dose Percent Not Assigned

Age Group Fully_Age0to9 Fully vaccinated Age 0 to 11 Dose 2 of An MRNA or AztraZeneca Vaccine or a single dose vaccine of a Janssen

Fully_Age10to19 Fully vaccinated Age 12 to 19

Fully_Age20to29 Fully vaccinated Age 20 to 29

Fully_Age30to39 Fully vaccinated Age 30 to 39

Fully_Age40to49 Fully vaccinated Age 40 to 49

Fully_Age50to59 Fully vaccinated Age 50 to 59

Fully_Age60to69 Fully vaccinated Age 60 to 69

Fully_Age70to79 Fully vaccinated Age 70 to 79

Fully_Age80+ Fully vaccinated Age 80+

Fully_NA Fully vaccinated Age Not Available

Age Group Cumulative FullyCum_Age0to9 Cumulative Fully vaccinated Age 0 to 11

FullyCum_Age10to19 Cumulative Fully vaccinated Age 12 to 19

FullyCum_Age20to29 Cumulative Fully vaccinated Age 20 to 29

FullyCum_Age30to39 Cumulative Fully vaccinated Age 30 to 39

FullyCum_Age40to49 Cumulative Fully vaccinated Age 40 to 49

FullyCum_Age50to59 Cumulative Fully vaccinated Age 50 to 59

FullyCum_Age60to69 Cumulative Fully vaccinated Age 60 to 69

FullyCum_Age70to79 Cumulative Fully vaccinated Age 70 to 79

FullyCum_80+ Cumulative Fully vaccinated Age 80+

Age Group Cumulative Percent FullyCum_NA Cumulative Fully vaccinated Age Not Available

FullyPer_Age0to9 Cumulative Percent Fully vaccinated Age 0 to 11 Cumulative Fully Vaccinated Age cohort/ Age cohort population

FullyPer_Age10to19 Cumulative Percent Fully vaccinated Age 12 to 19

FullyPer_Age20to29 Cumulative Percent Fully vaccinated Age 20 to 29

FullyPer_Age30to39 Cumulative Percent Fully vaccinated Age 30 to 39

FullyPer_Age40to49 Cumulative Percent Fully vaccinated Age 40 to 49

FullyPer_Age50to59 Cumulative Percent Fully vaccinated Age 50 to 59

FullyPer_Age60to69 Cumulative Percent Fully vaccinated Age 60 to 69

FullyPer_Age70to79 Cumulative Percent Fully vaccinated Age 70 to 79

FullyPer_80+ Cumulative Percent Fully vaccinated Age 80+

FullyPer_NA Cumulative Percent Fully vaccinated Age Not Available

This statistic displays the share of children immunized against measles, mumps and rubella(MMR) by 24 months of age in Ireland from 2000 to 2023. In 2001, ** percent of children were vaccinated against MMR, by 2023 this rate had increased to ** percent.

Time series data for the statistic Immunization, measles (% of children ages 12-23 months) and country Ireland. Indicator Definition:Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.The indicator "Immunization, measles (% of children ages 12-23 months)" stands at 90.00 as of 12/31/2024, the highest value since 12/31/2021. Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.12 percent compared to the value the year prior.The 1 year change in percent is 1.12.The 3 year change in percent is 0.0.The 5 year change in percent is -1.10.The 10 year change in percent is -3.23.The Serie's long term average value is 79.19. It's latest available value, on 12/31/2024, is 13.65 percent higher, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/1983, to it's latest available value, on 12/31/2024, is +800.00%.The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 12/31/2024, is -3.23%.

Ireland: Percent of children ages 12-23 months with measles immunization: The latest value from 2022 is 90 percent, unchanged from 90 percent in 2021. In comparison, the world average is 84 percent, based on data from 187 countries. Historically, the average for Ireland from 1983 to 2022 is 79 percent. The minimum value, 10 percent, was reached in 1983 while the maximum of 93 percent was recorded in 2013.

Please see FAQ for latest information on COVID-19 Data Hub Data Flows https://covid-19.geohive.ie/pages/helpfaqs

This statistic displays the share of children that have received the hepatitis B vaccination by 12 months of age in Ireland from 2009 to 2023. In 2023, ** percent of children had received the hepatitis B vaccination, a fall from a peak of ** percent in the years 2013 and 2014.

Ireland: Percent of children ages 12-23 months with DPT immunization: The latest value from 2022 is 93 percent, a decline from 94 percent in 2021. In comparison, the world average is 85 percent, based on data from 187 countries. Historically, the average for Ireland from 1980 to 2022 is 77 percent. The minimum value, 34 percent, was reached in 1980 while the maximum of 96 percent was recorded in 2013.

IntroductionGuidelines for the management of rheumatoid arthritis (RA) recommend using influenza and pneumococcal vaccinations to mitigate infection risk. The level of adherence to these guidelines is not well known in the UK. The aims of this study were to describe the uptake of influenza and pneumococcal vaccinations in patients with RA in the UK, to compare the characteristics of those vaccinated to those not vaccinated and to compare vaccination rates across regions of the UK.MethodsA retrospective cohort study of adults diagnosed with incident RA and treated with non-biologic immunosuppressive therapy, using data from a large primary care database. For the influenza vaccination, patients were considered unvaccinated on 1st September each year and upon vaccination their status changed to vaccinated. For pneumococcal vaccination, patients were considered vaccinated after their first vaccination until the end of follow-up. Patients were stratified by age 65 at the start of follow-up, given differences in vaccination guidelines for the general population.ResultsOverall (N = 15,724), 80% patients received at least one influenza vaccination, and 50% patients received a pneumococcal vaccination, during follow-up (mean 5.3 years). Of those aged below 65 years (N = 9,969), 73% patients had received at least one influenza vaccination, and 43% patients received at least one pneumococcal vaccination. Of those aged over 65 years (N = 5,755), 91% patients received at least one influenza vaccination, and 61% patients had received at least one pneumococcal vaccination. Those vaccinated were older, had more comorbidity and visited the GP more often. Regional differences in vaccination rates were seen with the highest rates in Northern Ireland, and the lowest rates in London.ConclusionsOne in five patients received no influenza vaccinations and one in two patients received no pneumonia vaccine over five years of follow-up. There remains significant scope to improve uptake of vaccinations in patients with RA.

Time series data for the statistic Immunization, Pol3 (% of one-year-old children) and country Ireland. Indicator Definition:Child immunization rate, polio, is the percentage of children ages 12-23 months who received polio vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.The indicator "Immunization, Pol3 (% of one-year-old children)" stands at 93.00 as of 12/31/2023. Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.The 1 year change in percent is 0.0.The 3 year change in percent is -1.06.The 5 year change in percent is -1.06.The 10 year change in percent is -3.12.The Serie's long term average value is 86.16. It's latest available value, on 12/31/2023, is 7.94 percent higher, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/1980, to it's latest available value, on 12/31/2023, is +29.17%.The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 12/31/2023, is -3.12%.

Ireland IE: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 95.000 % in 2016. This stayed constant from the previous number of 95.000 % for 2015. Ireland IE: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 83.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 96.000 % in 2014 and a record low of 34.000 % in 1980. Ireland IE: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ireland – Table IE.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Ireland IE: Immunization: HepB3: % of One-Year-Old Children data was reported at 95.000 % in 2016. This stayed constant from the previous number of 95.000 % for 2015. Ireland IE: Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 95.000 % from Dec 2010 (Median) to 2016, with 7 observations. The data reached an all-time high of 95.000 % in 2016 and a record low of 46.000 % in 2010. Ireland IE: Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ireland – Table IE.World Bank: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Ireland IE: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 92.000 % in 2016. This records a decrease from the previous number of 93.000 % for 2015. Ireland IE: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 78.000 % from Dec 1983 (Median) to 2016, with 34 observations. The data reached an all-time high of 93.000 % in 2015 and a record low of 10.000 % in 1984. Ireland IE: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ireland – Table IE.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Immunization against DPT of Ireland decreased by 4.30% from 93.0 % in 2022 to 89.0 % in 2023. Since the 1.05% rise in 2013, immunization against DPT dropped by 7.29% in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.

Published as part of Health in Ireland: Key Trends 2016 (Department of Health)